NEW YORK — Purigen said on Tuesday that it has struck a distribution deal for its automated nucleic acid purification system in certain Eastern European markets with the Institute of Applied Biotechnologies.
The benchtop instrument, called Ionic Purification System, uses isotachophoresis to extract, purify, and concentrate genomic RNA and DNA from cells and formalin-fixed, paraffin-embedded tissues. Launched in 2019, it received the CE mark in early 2021.
Under the deal, IAB will exclusively distribute and service the system, along with related microfluidic kits, in the Czech Republic, Hungary, Poland, Romania, and Slovakia.
Financial and other terms of the arrangement were not disclosed.